Abstract P108: Impact of the Covid-19 Pandemic on Hyperacute Stroke Treatment: Experience From a Comprehensive Stroke Centre in Singapore

• DOI: 10.1161/str.52.suppl_1.p108
• Publication Date: 2021-03-11T10:32:49Z
• Authors: Prakash R Paliwal; Benjamin Y Tan; Aloysius Leow; Sunny Sibi; Daniel Chor; Amanda Chin; Ying-Wei Yau; Gail Cross; Lily Wong; Magdalene Chia; Zhixuan Quak; Christopher Chua; David Tang; Ei T Zune; Jennifer Hung; Yihui Goh; Mingxue Jing; Anil Gopinathan; Cunli Yang; Aftab Ahmad; Deborah Khoo; Chang-Chuan Lee; Raymond C Seet; Vijay K Sharma; Hock-Luen Teoh; Leonard L Yeo; Bernard P Chan
• Keywords: Stroke; Pandemic; Acute stroke

Background: The Coronavirus disease 2019 (COVID-19) pandemic is rapidly evolving and affecting healthcare systems across the world. Singapore has escalated its alert level to Disease Outbreak Response System Condition (DORSCON) Orange, signifying severe with community spread. Objectives: We aimed study overall volume of AIS cases delivery hyperacute stroke services during DORSCON Orange. Methods: This was a single-centre, observational cohort performed at comprehensive centre responsible for in western region Singapore, as well providing care COVID-19 patients. All patients reviewed an acute activation Emergency Department (ED) from November April 2020 were included. processes timings, treatment clinical outcome variables collected. Results: studied 350 admitted through ED, 206 (58.9%) pre- 144 Across period, number activations showed significant decline (p =0.004, 95% CI 6.513 - -2.287), increased exponentially, whilst proportion receiving recanalization therapy remained stable ( p = 0.519, -1.605 2.702). Amongst that received therapy, early neurological outcomes terms change median NIHSS 24 hours (-4 versus -4, 0.685) largely similar between orange periods. Conclusions: decreased while current Singapore.